-
Something wrong with this record ?
Catheter ablation for non-paroxysmal atrial fibrillation. A review
S. Hassouna, P. Osmancik
Language English Country Czech Republic
Document type Journal Article, Review
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
38230517
DOI
10.5507/bp.2023.053
Knihovny.cz E-resources
- MeSH
- Electrophysiologic Techniques, Cardiac methods MeSH
- Atrial Fibrillation * MeSH
- Catheter Ablation * methods MeSH
- Humans MeSH
- Recurrence MeSH
- Pulmonary Veins * surgery MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Atrial fibrillation (AF), the most common cardiac arrhythmia is associated with increased morbidity and mortality. The higher mortality is due to the risk of heart failure and cardioembolic events. This in-depth review focuses on the strategies and efficacy of catheter ablation for non-paroxysmal atrial fibrillation. The main medical databases were searched for contemporary studies on catheter ablation for non-paroxysmal AF. Catheter ablation is currently proven to be the most effective treatment for AF and consists of pulmonary vein isolation as the cornerstone plus additional ablations. In terms of SR maintenance, it is less effective in non-paroxysmal AF than in paroxysmal patients. but the clinical benefit in non-paroxysmal patients is substantially higher. Since pulmonary vein isolation is ineffective, a variety of techniques have been developed, e.g. linear ablations, ablation of complex atrial fractionated electrograms, etc. Another paradox consists in the technique of catheter ablation. Despite promising results in early observation studies, further randomized studies have not confirmed the initial enthusiasm. Recently, a new approach, pulsed-field ablation, appears promising. This is an in-depth summary of current technologies and techniques for the ablation of non-paroxysmal AF. We discuss the benefits, risks and implications in the treatment of patients with non-paroxysmal AF.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24005427
- 003
- CZ-PrNML
- 005
- 20250415110421.0
- 007
- ta
- 008
- 240404s2024 xr da f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2023.053 $2 doi
- 035 __
- $a (PubMed)38230517
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Hassouna, Sabri $u Department of Cardiology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic $7 xx0331110
- 245 10
- $a Catheter ablation for non-paroxysmal atrial fibrillation. A review / $c S. Hassouna, P. Osmancik
- 520 9_
- $a Atrial fibrillation (AF), the most common cardiac arrhythmia is associated with increased morbidity and mortality. The higher mortality is due to the risk of heart failure and cardioembolic events. This in-depth review focuses on the strategies and efficacy of catheter ablation for non-paroxysmal atrial fibrillation. The main medical databases were searched for contemporary studies on catheter ablation for non-paroxysmal AF. Catheter ablation is currently proven to be the most effective treatment for AF and consists of pulmonary vein isolation as the cornerstone plus additional ablations. In terms of SR maintenance, it is less effective in non-paroxysmal AF than in paroxysmal patients. but the clinical benefit in non-paroxysmal patients is substantially higher. Since pulmonary vein isolation is ineffective, a variety of techniques have been developed, e.g. linear ablations, ablation of complex atrial fractionated electrograms, etc. Another paradox consists in the technique of catheter ablation. Despite promising results in early observation studies, further randomized studies have not confirmed the initial enthusiasm. Recently, a new approach, pulsed-field ablation, appears promising. This is an in-depth summary of current technologies and techniques for the ablation of non-paroxysmal AF. We discuss the benefits, risks and implications in the treatment of patients with non-paroxysmal AF.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a fibrilace síní $7 D001281
- 650 _2
- $a výsledek terapie $7 D016896
- 650 12
- $a katetrizační ablace $x metody $7 D017115
- 650 12
- $a venae pulmonales $x chirurgie $7 D011667
- 650 _2
- $a elektrofyziologické techniky kardiologické $x metody $7 D022062
- 650 _2
- $a recidiva $7 D012008
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Osmančík, Pavel, $d 1972- $u Department of Cardiology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic $7 xx0104796
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 168, č. 1 (2024), s. 1-14
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38230517 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y - $z 0
- 990 __
- $a 20240404 $b ABA008
- 991 __
- $a 20250415110427 $b ABA008
- 999 __
- $a ok $b bmc $g 2295210 $s 1215187
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 168 $c 1 $d 1-14 $e 20240115 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $n Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub $x MED00012606
- LZP __
- $b NLK116 $a Pubmed-20240404